BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15492568)

  • 1. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
    Berman RS; Feig BW; Hunt KK; Mansfield PF; Pollock RE
    Ann Surg; 2004 Nov; 240(5):852-7. PubMed ID: 15492568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
    Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
    Bourgeois E; Caulier MT; Rose C; Dupriez B; Bauters F; Fenaux P
    Leukemia; 2001 Jun; 15(6):950-3. PubMed ID: 11417482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status and problem of platelet transfusion for hematopoietic diseases: results from a questionnaire survey].
    Kato H; Handa M; Takamoto S
    Rinsho Ketsueki; 2006 Dec; 47(12):1514-20. PubMed ID: 17233469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.
    Hirooka M; Ochi H; Hiraoka A; Koizumi Y; Tanaka T; Sunago K; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Abe M; Joko K; Michitaka K; Hiasa Y
    J Gastroenterol Hepatol; 2020 Feb; 35(2):299-304. PubMed ID: 31318996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
    Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
    J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
    Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
    Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience.
    Bouvet M; Babiera GV; Termuhlen PM; Hester JP; Kantarjian HM; Pollock RE
    Surgery; 1997 Jul; 122(1):20-5. PubMed ID: 9225910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
    Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
    J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of splenectomy in non-Hodgkin's lymphoma.
    Kehoe JE; Daly JM; Straus DJ; DeCosse JJ
    Cancer; 1985 Mar; 55(6):1256-64. PubMed ID: 2578865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
    Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
    Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation.
    Banaji M; Bearman SI; Buckner CD; Clift RA; Bensinger WI; Petersen FB; Slichter SJ; McGuffin RW; Sanders JE; Stewart PS
    Am J Hematol; 1986 Jul; 22(3):275-83. PubMed ID: 3521264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the rate of reduction in platelet counts in recipients of hematopoietic stem and progenitor cell transplant: clinical implications for platelet transfusion therapy.
    del Rosario ML; Kao KI
    Transfusion; 1997; 37(11-12):1163-8. PubMed ID: 9426640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
    Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
    Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative embolization of the splenic artery in patients that underwent splenectomy for immune thrombocytopenic purpura.
    Baú PC; Cavazolla SA; Souza HP; Garicochea B
    Acta Cir Bras; 2007; 22(6):470-3. PubMed ID: 18235936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
    Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
    Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative complications after splenectomy for hematologic malignancies.
    Horowitz J; Smith JL; Weber TK; Rodriguez-Bigas MA; Petrelli NJ
    Ann Surg; 1996 Mar; 223(3):290-6. PubMed ID: 8604910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
    Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.